CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today announced that it will report financial results for the second quarter of 2007 on Monday, August 13, 2007, after the U.S. financial markets close.
